معرفی
Kathryn Whitehead is Professor of Chemical Engineering at Carnegie Mellon University with courtesy appointment in Biomedical Engineering. Her lab engineers lipid nanoparticles (LNPs) for RNA/protein delivery with applications in vaccines, cancer therapy, and maternal-infant health.
Research breakthroughs:
- LNP chemistry-immunogenicity relationships
- Oral delivery platforms for biologics
- Breast milk cell engineering for infant therapy
- Pregnancy-safe nanotherapeutics
Recent work explains immune activation mechanisms of COVID-19 vaccine components and enables organ-targeted RNA delivery. Awards include NIH Director’s Innovator Award and TED Talk on LNP technology. Patents licensed for therapeutic development.
۰مقاله ثبتشده
